CUVITRU

Product NDC
0944-2850
Requested package NDC
0944-2850-07
11-digit product format
009442850
Labeler code
0944
Product ID
0944-2850_195585b0-5cd1-4638-9765-224db70d6e44
Type
PLASMA DERIVATIVE
Nonproprietary name
Immune Globulin Subcutaneous (Human)
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
Takeda Pharmaceuticals America, Inc.
Application
BLA125596
Marketing category
BLA
Marketing start
2016-10-18
Substance
HUMAN IMMUNOGLOBULIN G
Active strength
200 mg/mL
Pharmacologic classes
Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
CUVITRU
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HUMAN IMMUNOGLOBULIN G200 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
66Y330CJHSInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 10 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1809061Internal RxNorm lookup
1809066Internal RxNorm lookup
1809068Internal RxNorm lookup
1809076Internal RxNorm lookup
1813415Internal RxNorm lookup
1813417Internal RxNorm lookup
1813420Internal RxNorm lookup
1813423Internal RxNorm lookup
1813424Internal RxNorm lookup
2117971Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9aad7ec9-6097-4805-8f1b-898bec35f218Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0944-2850-01CUVITRU1 in 1 CARTONINJECTION, SOLUTION119
0944-2850-02CUVITRU5 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION519
0944-2850-03CUVITRU1 in 1 CARTONINJECTION, SOLUTION119
0944-2850-04CUVITRU10 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION1019
0944-2850-05CUVITRU1 in 1 CARTONINJECTION, SOLUTION119
0944-2850-06CUVITRU20 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION2019
0944-2850-07CUVITRU1 in 1 CARTONINJECTION, SOLUTION119
0944-2850-08CUVITRU40 mL in 1 VIAL, SINGLE-USEINJECTION, SOLUTION4019
0944-2850-09CUVITRU1 in 1 CARTONINJECTION, SOLUTION119
0944-2850-10CUVITRU50 mL in 1 BOTTLE, GLASSINJECTION, SOLUTION5019

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0944-2850-01ML - Milliliter0944-2850c58db1fc-0e11-4002-8d41-96f00f55f7fc12016-11-08
0944-2850-02ML - Milliliter0944-285020d36891-5cb5-4e05-9b58-345ed79c5bd312016-11-08
0944-2850-03ML - Milliliter0944-2850f5021b91-d03e-4c36-ada4-a520ed2a68ae12016-11-08
0944-2850-04ML - Milliliter0944-28509705ff29-87d6-4741-b16d-6528bea1b6cc12016-11-08
0944-2850-05ML - Milliliter0944-2850da8fb69e-89f3-4e44-8fe0-6de09409984112016-11-08
0944-2850-06ML - Milliliter0944-2850c3580c6f-014a-4f58-ae2c-57452369b98a12016-11-08
0944-2850-07ML - Milliliter0944-28507f9f1d01-9cf7-4cee-9feb-bd1bdf9816af12016-11-08
0944-2850-08ML - Milliliter0944-285078519672-4a4a-405b-a25a-d043b5279f6912016-11-08
0944-2850-09ML - Milliliter0944-2850fd4d2d8d-34db-4133-b0ce-d99666dd73af12019-08-06
0944-2850-10ML - Milliliter0944-2850333cde41-e012-4ff1-b52c-780ed0a024e312019-08-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0944-2850CUVITRU (IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN)) INJECTION, SOLUTION [TAKEDA PHARMACEUTICALS AMERICA, INC.]18Current NDC, Legacy NDC, 10 package rows20250311_9aad7ec9-6097-4805-8f1b-898bec35f218.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CUVITRUIMMUNE GLOBULIN SUBCUTANEOUS (HUMAN)Takeda Pharmaceuticals America, Inc.9aad7ec9-6097-4805-8f1b-898bec35f2182025-11-25Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA125596
ndc (package): 0944-2850-07
ndc (product): 0944-2850
ndc11 (package): 00944285007

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125596CuvitruImmune Globulin Subcutaneous (Human), 20% Solution351(a)Rx2026-10-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1813417CUVITRU 20 % in 10 mL InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
1813420CUVITRU 20 % in 20 mL InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
1813424CUVITRU 20 % in 40 mL InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
1813415CUVITRU 20 % in 5 mL InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
2117971CUVITRU 20 % in 50 ML InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
1809068immunoglobulin G, human 20 % in 10 ML InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
1809066immunoglobulin G, human 20 % in 20 ML InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
1813423immunoglobulin G, human 20 % in 40 mL InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
1809076immunoglobulin G, human 20 % in 5 ML InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
1809061immunoglobulin G, human 20 % in 50 ML InjectionPSN9aad7ec9-6097-4805-8f1b-898bec35f21819
181341710 ML immunoglobulin G, human 200 MG/ML Injection [Cuvitru]SBD9aad7ec9-6097-4805-8f1b-898bec35f21819
181342020 ML immunoglobulin G, human 200 MG/ML Injection [Cuvitru]SBD9aad7ec9-6097-4805-8f1b-898bec35f21819
181342440 ML immunoglobulin G, human 200 MG/ML Injection [Cuvitru]SBD9aad7ec9-6097-4805-8f1b-898bec35f21819
18134155 ML immunoglobulin G, human 200 MG/ML Injection [Cuvitru]SBD9aad7ec9-6097-4805-8f1b-898bec35f21819
211797150 ML immunoglobulin G, human 200 MG/ML Injection [Cuvitru]SBD9aad7ec9-6097-4805-8f1b-898bec35f21819
180906810 ML immunoglobulin G, human 200 MG/ML InjectionSCD9aad7ec9-6097-4805-8f1b-898bec35f21819
180906620 ML immunoglobulin G, human 200 MG/ML InjectionSCD9aad7ec9-6097-4805-8f1b-898bec35f21819
181342340 ML immunoglobulin G, human 200 MG/ML InjectionSCD9aad7ec9-6097-4805-8f1b-898bec35f21819
18090765 ML immunoglobulin G, human 200 MG/ML InjectionSCD9aad7ec9-6097-4805-8f1b-898bec35f21819
180906150 ML immunoglobulin G, human 200 MG/ML InjectionSCD9aad7ec9-6097-4805-8f1b-898bec35f21819
211797150 ML Cuvitru 200 MG/ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813415CUVITRU 1 GM per 5 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813417CUVITRU 2 GM per 10 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813417CUVITRU 20 % per 10 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813420CUVITRU 20 % per 20 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813424CUVITRU 20 % per 40 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813415CUVITRU 20 % per 5 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
2117971CUVITRU 20 % per 50 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813420CUVITRU 4 GM per 20 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813424CUVITRU 8 GM per 40 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1809076immunoglobulin G, human 1 GM per 5 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1809061immunoglobulin G, human 10 GM per 50 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1809068immunoglobulin G, human 2 GM per 10 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1809068immunoglobulin G, human 20 % per 10 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1809066immunoglobulin G, human 20 % per 20 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813423immunoglobulin G, human 20 % per 40 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1809076immunoglobulin G, human 20 % per 5 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1809061immunoglobulin G, human 20 % per 50 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1809066immunoglobulin G, human 4 GM per 20 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819
1813423immunoglobulin G, human 8 GM per 40 ML InjectionSY9aad7ec9-6097-4805-8f1b-898bec35f21819

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0944-2850-07009442850071 VIAL, SINGLE-USE in 1 CARTON (0944-2850-07) / 40 mL in 1 VIAL, SINGLE-USE (0944-2850-08) 2016-10-180000-00-00NoNoCurrent